Hi, what are you looking for?
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin...
– In the 22nd Dec 2013 edition of Israel’s good news: ECONOMY & BUSINESS Inflation falls by 0.4 per cent. An 8.1% drop...
– New York Stock Exchange listed, retail clothing company, The Jones Group yesterday announced it has entered into an agreement with Sycamore Partners of...
– President Putin made good on his promise to release Khodorkovsky and in surprisingly quick time. – – Much sooner than anyone expected Mikhael...
– Takeda Israel Ltd. will be headquartered in the Tel Aviv area and will market products with an initial focus on oncology. – Takeda...
– The funding will be used by Dr. Ciechanover in the development of drugs for the treatment of Kidney disorders as well as Ovarian...
– The ceremony, which took place at Nasa’s Ames Research Centre in Mountain View, California was attended by the highest fliers in the world...
– Initial results for BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis) – CEO Kinneret Savitsky – BioLineRx (NASDAQ:...
– Indianapolis based, US shopping centre developer, the Simon Property Group (“Simon Group”), is America’s largest shopping center company, with annual revenues of US$4.8...